Skip to main content
Tweets by AES2020
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Better Outcomes through Diveristy
Pediatric Highlights Poster
Partners Against Mortality in Epilepsy
Head of PMS Group
UCB Pharma, Tokyo, Japan
(777) Safety and Efficacy of Oral Levetiracetam as Adjunctive Therapy for Japanese Patients with Primary Generalised Tonic-Clonic Seizures in Clinical Practice: Results of the Post-marketing Surveillance
Monday, December 7, 2020
9:00 AM – 10:30 AM US EST